| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $51,406,268 ) (Continued on the next page) |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | T2331575 | Children's Hospitals Graduate Medical Education Payment Program | 08 | 8 | HRSA | 12/1/2025 | $1,672,276 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | T2331575 | Children's Hospitals Graduate Medical Education Payment Program | 09 | 8 | HRSA | 2/13/2026 | $0 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | T2331575 | Children's Hospitals Graduate Medical Education Payment Program | 09 | 8 | HRSA | 2/13/2026 | $0 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AG081840 | Pericyte control of capillary perfusion in the Alzheimer's disease brain | 000 | 4 | NIH | 2/2/2026 | $759,966 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01HD111410 | Development of a Multiplex Proteomics Assay for High-Throughput Newborn Screening of a New Set of Treatable Neonatal Diseases | 000 | 4 | NIH | 1/30/2026 | $568,132 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | K08AI166072 | Dissecting the molecular regulation of T cell localization and function within the Mycobacterium tuberculosis granuloma | 000 | 5 | NIH | 1/28/2026 | $183,968 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | UM1DA058220 | 'Mosaicism in Human Tissues, from Telomere to Telomere to RFA-22-013: "Somatic Mosaicism across Human Tissues Program: Genome Characterization Centers." | 002 | 4 | NIH | 5/14/2026 | $6,749,998 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01ES025169 | TIDES III: Endocrine Disruption, Hormones, and Sex Differences in Adolescent Airway Health | 000 | 10 | NIH | 5/14/2026 | $1,388,864 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01HL126523 | Unraveling respiratory rhythm generation in medullary and supramedullary networks | 001 | 11 | NIH | 5/19/2026 | $908,821 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI170777 | Impairment of anti-Plasmodium T cell memory by type I Interferon Signaling | 000 | 4 | NIH | 5/19/2026 | $735,776 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | K99AI182458 | Elucidating a novel respiratory-mammary axis of T cell immunity | 000 | 2 | NIH | 1/29/2026 | $34,331 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R37CA266777 | The IL-18-IFNγ axis predicts response to immunotherapy | 000 | 4 | NIH | 1/29/2026 | $714,132 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI014102 | Mitochondrial DNA of Normal and Mutant Trypanosomes | 000 | 49 | NIH | 4/29/2026 | $1,158,683 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI172824 | Parasite and host cell factors involved in the formation and persistence of Plasmodium vivax hypnozoites | 001 | 4 | NIH | 4/30/2026 | -$667,525 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01DK144249 | Selectively disrupting heterochromatin to improve function of hepatocytes reprogrammed from human fibroblasts | 000 | 1 | NIH | 5/5/2026 | $724,950 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI151167 | Manipulating alpha(v) integrins on B cells to promote lung-resident B cell responses | 000 | 5 | NIH | 3/27/2026 | $767,781 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01DA048036 | Molecular genetic mechanisms of opioid receptor signaling | 000 | 9 | NIH | 4/21/2026 | $776,335 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01HD109089 | Bifidobacterium infantis supplementation in early life to improve immunity in infants exposed to HIV: a randomized, placebo-controlled, double-blind trial | 000 | 5 | NIH | 5/12/2026 | $686,430 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01DE033703 | Leveraging Data for Infants with Cleft to Grow and Flourish: The BLOOM Study | 002 | 3 | NIH | 5/11/2026 | $786,044 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | T2331575 | Children's Hospitals Graduate Medical Education Payment Program | 10 | 8 | HRSA | 3/17/2026 | $485,034 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | T2331575 | Children's Hospitals Graduate Medical Education Payment Program | 10 | 8 | HRSA | 3/17/2026 | $862,616 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01DA056370 | Regulation of Opioid Sensitivity and Tolerance by Ubiquitin Ligase Signaling | 000 | 5 | NIH | 4/21/2026 | $605,352 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI183642 | Targeted vaccines against pulmonary NTM infections in vulnerable populations | 001 | 2 | NIH | 4/3/2026 | $0 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI132819 | Mechanisms of T Cell Quiescence and Exhaustion | 000 | 7 | NIH | 3/6/2026 | $645,962 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | U01DA060443 | Deep Analysis of Transcriptome to Understand the Genetics of Substance Use Disorders in Rats | 000 | 2 | NIH | 3/27/2026 | $882,279 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI170914 | Functional exploration of a deep Mycobacterium tuberculosis phosphoproteome | 000 | 4 | NIH | 1/22/2026 | $593,030 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01MH123442 | Advancing Suicide Intervention Strategies for Teens During High Risk Periods | 000 | 5 | NIH | 1/22/2026 | $851,602 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01HL170607 | Mechanisms by which red blood cells contribute cardiopulmonary bypass associated inflammation | 000 | 3 | NIH | 3/9/2026 | $826,322 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01HL163103 | Hexosamine biosynthesis pathway metabolism during cardiac hypertrophy | 000 | 4 | NIH | 2/27/2026 | $740,074 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01HD106628 | Supraphysiologic Shear Stresses Associated with Cardiopulmonary Bypass are Sufficient to Activate RIKP3 Signaling | 000 | 5 | NIH | 3/3/2026 | $725,965 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R25NS141155 | Summer Undergraduate Program to Advance Research and Quality in Pain and Neurological Health | 000 | 2 | NIH | 2/24/2026 | $129,113 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | U01AI165455 | Collective Responses to Malaria Vaccination | 000 | 5 | NIH | 1/20/2026 | $700,000 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AG081840 | Pericyte control of capillary perfusion in the Alzheimer's disease brain | 001 | 4 | NIH | 2/25/2026 | $84,440 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | K01AI187782 | Mechanisms of Innate Immune Activation in Mitochondrial Disease Onset and Progression | 000 | 2 | NIH | 1/10/2026 | $122,562 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | K24AR085177 | Mentoring the next generation of researchers in pediatric autoimmunity | 000 | 2 | NIH | 1/13/2026 | $211,662 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01MH135568 | Atypical Development in Infants and Toddlers: Computational Attentional Signatures through Mobile Eye Tracking | 000 | 3 | NIH | 12/23/2025 | $880,471 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI180452 | Transporter function of the Mycobacterium tuberculosis PE/PPE proteins | 000 | 3 | NIH | 1/17/2026 | $856,417 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01DK136980 | Interrogating The Biology Of Human Lupus Nephritis Using Single Cell Resolution Spatial Transcriptomics | 000 | 3 | NIH | 1/20/2026 | $801,241 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | K01DA058543 | Dissociating respiratory depression and analgesia via a data-driven model of interacting respiratory and pain networks | 000 | 4 | NIH | 3/19/2026 | $100,975 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01DE032663 | Influence of viral and immune interventions on early events following oral SIV infection | 001 | 4 | NIH | 4/16/2026 | $79,837 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R37CA266777 | The IL-18-IFNγ axis predicts response to immunotherapy | 001 | 4 | NIH | 4/16/2026 | $79,347 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R21HD118297 | Use of Oscillometry for the Evaluation of Pulmonary Function Following Pediatric Acute Respiratory Failure. | 000 | 2 | NIH | 5/12/2026 | $197,700 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | T32HD007233 | Academic Pediatric Infectious Disease | 000 | 44 | NIH | 5/12/2026 | $208,548 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01CA300296 | Menin and Ewing Sarcoma Metastasis | 000 | 1 | NIH | 3/30/2026 | $636,097 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R00CA263161 | Characterizing the role of MARCH5 in apoptosis regulation in acute myeloid leukemia | 000 | 5 | NIH | 3/30/2026 | $248,977 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01HL183249 | Home Air Pollution in Children with Cystic Fibrosis (HEROIC-CF) | 000 | 1 | NIH | 5/5/2026 | $893,522 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01GM163160 | AI-designed Nanobodies for Detection and Manipulation Applications Inside Living Cells | 000 | 1 | NIH | 4/7/2026 | $2,096,292 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI192661 | Molecular and Functional Dissection of a Divergent mRNA Export Pathway | 000 | 1 | NIH | 5/7/2026 | $696,562 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01HD111410 | Development of a Multiplex Proteomics Assay for High-Throughput Newborn Screening of a New Set of Treatable Neonatal Diseases | 001 | 4 | NIH | 4/6/2026 | $63,126 |
|
